FERNANDEZ ARANCIBIA, MARIO
Preferred name
FERNANDEZ ARANCIBIA, MARIO
Main Affiliation
Email
mariofernandez@udd.cl
ORCID
0000-0001-6424-4977
Scopus Author ID
7403378256, 14323072400, 6506381046
41 results
Now showing 1 - 10 of 41
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Advances in Label-Free Detection of Non-Muscle Invasive Bladder Cancer: A Critical Review(MDPI AG, 2025-08-12) ;Gabriela Vera ;Javier Cerda-Infante; ;Miguel Sánchez-EncinasPablo A. Rojas<jats:p>Non-muscle invasive bladder cancer (NMIBC) accounts for about 75% of new bladder cancer diagnoses. Early detection improves survival, yet routine white-light cystoscopy is invasive, costly, and can miss up to 45% of flat or small lesions. These shortcomings have prompted development of label-free diagnostic tools that read the intrinsic optical, electrical, or mechanical signatures of urinary biomarkers without added labels. This review examines recent engineering advances in such platforms for NMIBC detection, focusing on analytical performance, readiness for clinical translation, and remaining barriers to adoption. We compare each technology with conventional cytology using key metrics such as limit of detection, diagnostic accuracy, analysis time, cohort size, and stage of clinical development. Surface-enhanced Raman spectroscopy and interferometric flow cytometry offer femtomolar sensitivity and more than 98% accuracy within minutes, while compact electrochemical sensors targeting NMP22, Galectin-1, and microRNAs reach sub-picogram levels on disposable chips. Standardized sample handling, multicenter validation, and robust cost-effectiveness data are now essential for these tools to advance point-of-care NMIBC surveillance.</jats:p>1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction(2017) ;Grant P. Redrow ;Charles C. Guo ;Maurizio A. Brausi ;Jonathan A. ColemanScopus© Citations 30 5 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 6 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Immediate postoperative morbidity in patients with indwelling double-J stent versus overnight-externalized ureteral catheter after tubeless percutaneous nephrolithotomy: a prospective, randomized study(2013) ;Alejandro Mercado; ;Pedro Recabal ;Daniela FleckRodrigo LedezmaScopus© Citations 5 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection(2024) ;Roger Li ;Patrick J. Hensley ;Shilpa Gupta ;Hikmat Al-AhmadieMarko BabjukScopus© Citations 15 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy(2010) ;Jay D. Raman ;Casey K. Ng ;Douglas S. Scherr ;Vitaly MargulisYair Lotan4Scopus© Citations 154 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Mortalidad por cáncer de prĂłstata en Chile: tendencias del perĂodo 1955-2019(2022) ;J. Francisco LĂłpez; Fernando Coz5Scopus© Citations 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Postoperative morbidity of tubeless versus conventional percutaneous nephrolithotomy: a prospective comparative study(2011) ;Fernando Marchant ;Pedro Recabal; ;Francisco OsorioJaviera BenavidesScopus© Citations 21 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer(2019); ;Maurizio Brausi ;Peter E. Clark ;Michael S. CooksonH. Barton GrossmanScopus© Citations 50 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Impact of arsenic exposure on clinicopathological characteristics of bladder cancer: A comparative study between patients from an arsenic-exposed region and nonexposed reference sites(2020); ;Patricio Valdebenito; ;Jorge SegebreEduardo ChaparroScopus© Citations 10 1 3